human-monoclonal-antibody Videos
3 videos found
Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines, monoclonal antibodies, biosimilars and/or biobetters, and other therapeutic proteins. ...
Feb. 12, 2018
Feb. 13, 2023
Tonix Pharmaceuticals Holding Corp. CEO Seth Lederman talks to Proactive about the New Jersey-based clinical-stage biopharmaceutical company's 2021 highlights. Lederman says the group ended the year with $179 million in cash and cash equivalents, entering 2022 'poised for growth.' Lederman highlights the FDA's recent award of Orphan-Drug designation for Tonix's TNX-2900 to treat Prader Willi ...
Nov. 30, 2022